Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Member In Focus
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • PetriDish Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

Xultophy® approved in Canada for the treatment of adults with type 2 diabetes

by administrator | Apr 18, 2018 | News, Novo Nordisk

See original story here Once-daily Xultophy® has been shown to help patients achieve blood glucose targets Novo Nordisk announced today that Health Canada has approved Xultophy®as an adjunct to lifestyle modifications, for the once-daily treatment of adults with type...

Recent Posts

  • Nova Scotia femtech startup Elle MD raises $1.1 million
  • Celebrating a Year of Impact and Momentum at Our 2026 AGM
  • 3DBioFibR and FinLeaf Technologies Recognized at Startupfest 2026
  • Manufacturing the Future of Life‑Saving Medicine in Nova Scotia
  • BIOTECanada Opens Canada Pavilion at BIO 2026 Amid Major Policy Momentum for Canadian Biotech
No comments to show.
[buddybot_chat id=1]

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow